Biosynthesis of copper oxide nanoparticles (CuONPs) in a cost-effective and eco-friendly way has gained its importance. CuONPs has been prepared from copper sulfate by using Adiantum lunulatum whole plant extract. CuONPs have been characterized by X-ray diffraction, Fourier transform infrared spectroscopic, transmission electron microscope, etc. Mono-disperse, spherical, pure, and highly stable CuONPs have formed with an average diameter of 6.5 ± 1.5 nm. Biosynthesized CuONPs at different concentrations were applied to seeds of Lens culinaris. Physiological characteristics were investigated in the germinated seeds. Roots obtained from the seeds treated with 0.025 mgmL−1 concentration of CuONPs showed highest activity of different defence enzymes and total phenolics. However, at higher concentration it becomes close to control. It showed gradual increase of antioxidative enzymes, in accordance with the increasing dose of CuONPs. Likewise, lipid peroxidation and proline content gradually increased with the increasing concentration. Reactive oxygen species and nitric oxide generation was also altered due to CuONPs treatment indicating stress signal transduction. Finally, this study provides a new approach of the production of valuable CuONPs, is a unique, economical, and handy tool for large scale saleable production which can also be used as a potent plant defence booster instead of other commercial uses.
PI3K/AKT/mTOR pathway is one of the frequently disrupted signaling pathways in renal cell carcinoma (RCC) that plays a significant role in tumor formation, disease progression and therapeutic resistance. Therefore, novel natural molecules targeting the critical proteins of this pathway will provide the best alternative to existing drugs, which are toxic and develops resistance. Recent studies have recognized the anti-cancer therapeutic potential of mycocompounds. The current study is focused on screening various mycocompounds from Astraeus hygrometricus against key cancer signaling proteins phosphoinositide 3‐kinase (PI3K), protein kinase B, PKB (AKT1) and mammalian target of rapamycin (mTOR). We also studied in-silico cancer cells cytotoxicity and ADMET (absorption, distribution, metabolism, excretion and toxicity) profiles to elucidate the molecular mechanism against RCC and also to uncover the pharmacokinetic profile of these compounds. Astrakurkurone and Ergosta-4,6, 8-(14) 22-tetraene-3-one were the two most efficacious compounds with highest interaction scores and bonding. These compounds were both active against RCC4 and VMRC-RCZ cell lines of RCC. The ADME profiles of both were satisfactory based on druglikeness and bioavailability score criteria. Thus, this proposed study identified astrakurkurone and ergosta-4,6, 8-(14) 22-tetraene-3-one as potential anticancer drug candidates, and provides comparative structural insight into their binding to the 3 protein kinases.
Kidney stone disease (KSD) or nephrolithiasis (NL), is a serious clinical concern that gradually poses threat to global health and economy. The frequency of KSD is rapidly increasing and about 12% of the Indian population are suffering from this disease. In this scenario, we studied the incidence and age group stratification of KSD in the eastern part of India. Furthermore, patients with GRHPR mutation were highly predominant. Furthermore, real time quantitative PCR expression and protein expression through immunoblotting along with protein activity & computational analysis were carried out in patients with GRHPR mutation. Our findings revealed that the candidates of the early age group are prone to hyperoxaluria moreover a potent and frequent mutation in the GRHPR gene is widely present in this age group. Further, biochemical tests such as serum creatine, serum urea, serum and urinary calcium were carried out for the patients along with age matched controls. Moreover, the actual underlying cause of nephrolithiasis for lower age groups still remains unclear. The study revealed that mutations were more often found in GRHPR, AGXT, and HOGA1 genes in the study cohort.